Showing results (811-820 of 5,007) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|September 28, 2018
A Simplified Risk Stratification Method for Women With Stage I Endometrial CarcinomaMohamed A Elshaikh, Ankit Modh, Sharif Sakr, et al.
American Journal of Clinical Oncology|April 12, 2019
Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional StudyNadia D Ali, Kristen Donohue, Shadi Zandieh, et al.
American Journal of Clinical Oncology|April 12, 2019
Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI)Faisal Ahmed, Paul J Christos, Prabhsimranjot Singh, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
American Journal of Clinical Oncology|December 1, 1988
Peripheral neuropathy and low dose cisplatinA Greenspan, J Treat
American Journal of Clinical Oncology|May 5, 2018
Routine Adaptive Replanning of p16-Positive Stage N2b Oropharyngeal Cancer: Quality Improvement or Waste of Time?James H Zhu, Robert J Amdur, Bo Lu, et al.
American Journal of Clinical Oncology|May 5, 2018
Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma: A Cost-Utility AnalysisJacques Raphael, Zhuolu Sun, Georg A Bjarnason, et al.
American Journal of Clinical Oncology|May 5, 2018
The University of Florida Department of Radiation Oncology Guidelines for Treatment of Differentiated Thyroid Cancer With I-131 or External-beam RadiotherapyRobert J Amdur, Roi Dagan
American Journal of Clinical Oncology|April 7, 2018
Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal CancerVaagn Andikyan, Annie Kim, Herbert F Gretz, et al.
American Journal of Clinical Oncology|November 7, 2019
Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal CancerCheng-Chun Tai, Wei-Shone Chen, Jeng-Kai Jiang, et al.
Pageof 501